Iron Dysregulation: Looking Deeper Into Iron Metabolism
Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA
Quick Answer
Iron dysregulation occurs when the body’s ability to absorb, transport, or utilise iron is impaired—often despite “normal” ferritin levels. Chronic inflammation can disrupt iron metabolism through the hormone hepcidin, leading to functional iron deficiency, where iron is present in the body but unavailable to cells. Looking beyond ferritin to markers such as transferrin, transferrin saturation, and inflammation markers provides a more accurate assessment of iron status.
Understanding Iron Dysregulation
Iron is essential for oxygen transport, mitochondrial energy production, immune function, and cognitive performance. When iron metabolism becomes dysregulated, symptoms such as fatigue, poor concentration, reduced exercise tolerance, and increased susceptibility to infections may develop (1). These patterns commonly overlap with individuals seeking support for chronic fatigue.
Ferritin is commonly used to assess iron stores, but it does not always reflect how well iron is being utilised. Because ferritin is an acute-phase reactant, levels may appear normal or elevated during inflammation, masking underlying functional iron deficiency (2,3).
The Role of Chronic Inflammation
Chronic inflammation—associated with autoimmune disease, persistent infection, metabolic dysfunction, or obesity—has a profound impact on iron regulation (4).
A key regulator in this process is hepcidin, a liver-derived hormone that controls iron absorption from the intestine and the release of iron from storage sites such as macrophages and hepatocytes (5).
Inflammatory cytokines stimulate hepcidin production, reducing intestinal iron absorption and trapping iron within cells. This leads to functional iron deficiency, where circulating iron is insufficient for erythropoiesis and cellular metabolism despite adequate or elevated iron stores (6,7).
Markers That Provide Deeper Insight
Accurately identifying iron dysregulation requires a broader panel than ferritin alone. Important markers include:
Transferrin
Transferrin is the primary iron transport protein in blood. Low transferrin levels may reflect inflammation or poor protein status, while elevated transferrin often indicates iron deficiency as the body attempts to increase iron transport capacity (8).
Transferrin Saturation
Transferrin saturation reflects the proportion of transferrin bound to iron. Values below ~20% suggest limited iron availability, whereas levels above ~45% may indicate iron overload or impaired iron regulation (9).
Inflammation Markers (CRP and ESR)
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) help determine whether inflammation is contributing to impaired iron absorption or utilisation. Elevated markers can explain iron-restricted erythropoiesis even when ferritin is within range (10).
Why Deeper Testing Matters
Evaluating iron markers together allows practitioners to distinguish between absolute iron deficiency, functional iron deficiency, and iron sequestration due to inflammation. This reduces the risk of inappropriate iron supplementation, which may be ineffective or harmful when iron is trapped at the cellular level (11,12).
Because iron absorption occurs primarily in the small intestine, disturbances in digestion and microbial balance may also play a role. Exploring the gut microbiome can be an important part of understanding iron dysregulation.
When to Consider Further Investigation
A comprehensive iron assessment may be warranted if you experience:
- Persistent fatigue despite normal ferritin
- Brain fog or reduced exercise tolerance
- Frequent infections or impaired recovery
- Known inflammatory, autoimmune, or metabolic conditions
Frequently Asked Questions
Can ferritin be normal but iron still be functionally low?
Yes. Ferritin reflects iron storage but does not reliably indicate iron availability to tissues, particularly in the presence of inflammation (2).
Is functional iron deficiency the same as iron deficiency anaemia?
No. Functional iron deficiency refers to impaired iron utilisation and may occur before anaemia develops or without significant changes in haemoglobin (6).
Is iron supplementation always appropriate?
Not necessarily. When iron dysregulation is driven by inflammation, addressing underlying causes may be more effective than iron supplementation alone (11).
Key Insights
- Iron metabolism is tightly regulated and highly sensitive to inflammation
- Hepcidin plays a central role in functional iron deficiency
- Ferritin alone does not provide a complete picture of iron status
- Interpreting multiple iron and inflammation markers improves diagnostic accuracy
Takeaway
Iron health is rarely as simple as a single blood test. When symptoms persist despite “normal” ferritin, a deeper evaluation of iron metabolism can reveal clinically meaningful patterns that standard testing often misses.
Next Steps
Addressing iron dysregulation often involves identifying and reducing inflammatory drivers, supporting gut and metabolic health, and interpreting iron markers in clinical context. In some individuals, iron-related symptoms overlap with endocrine patterns such as thyroid dysfunction, reinforcing the importance of whole-system assessment (14).
References
- Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001.
- Wang W et al. Ferritin as an inflammatory marker. Clin Chim Acta. 2010.
- Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker. Metallomics. 2014.
- Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005.
- Ganz T. Hepcidin and iron regulation. Blood. 2011.
- Nemeth E et al. Hepcidin-mediated iron regulation in inflammation. Science. 2004.
- Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Blood. 2015.
- Cook JD et al. Serum transferrin receptor and iron deficiency. Blood. 1993.
- Oustamanolakis P, Koutroubakis IE. Iron deficiency diagnosis in inflammatory states. World J Gastroenterol. 2011.
- Means RT. Iron deficiency and inflammation. Hematology Am Soc Hematol Educ Program. 2013.
- Pasricha SR et al. Risks and benefits of iron supplementation. Lancet Haematol. 2021.
- Litton E et al. Safety of iron therapy in inflammation. BMJ. 2013.
- Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007.
- Duntas LH. Thyroid disease and anemia. Thyroid. 2015.
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015.
